Trump Science Policy
Trump administration's approach to federal science funding, research priorities, and science policy reform including NIH grants and research oversight.
2 events tracked
Latest in Trump Science Policy· Oct 7
The Trump administration's delays in funding processes are creating uncertainty for HIV research initiatives, with potential ripple effects across the healthcare innovation ecosystem. Postponements in federal research grant allocations risk slowing drug development pipelines and reducing revenues for biotech and pharmaceutical companies that depend on government funding. The funding delays operate through direct impacts on grant distribution, which then cascade to institutions and companies reliant on federal research dollars for their operations and development timelines.
- Single source15 days ago
Trump administration postponements jeopardize HIV research funding
Delays from the Trump administration are putting HIV research funding at risk, affecting networks that also work on other infectious disease treatments and participated in Covid vaccine testing.
The New York Times
- Single source29 days ago
Trump drops proposal to create NIH grant veto commission
Trump reverses course on restricting NIH grant controls, abandoning a planned policy shift.
The New York Times